AI assistant
Sending…
CLEARONE INC — Director's Dealing 2021
May 19, 2021
35252_dirs_2021-05-18_97aae1b0-35c3-434d-b84d-215ece7b12cb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLEARONE INC (CLRO)
CIK: 0000840715
Period of Report: 2021-05-14
Reporting Person: BAGLEY EDWARD D (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-14 | Common Stock | P | 2000 | $2.38 | Acquired | 8350357 | Direct |
| 2021-05-14 | Common Stock | P | 3000 | $2.35 | Acquired | 8353357 | Direct |
| 2021-05-14 | Common Stock | P | 14000 | $2.30 | Acquired | 8367357 | Direct |
| 2021-05-17 | Common Stock | P | 3000 | $2.30 | Acquired | 8370357 | Direct |
| 2021-05-17 | Common Stock | P | 5000 | $2.2791 | Acquired | 8375357 | Direct |
| 2021-05-17 | Common Stock | P | 5000 | $2.29990 | Acquired | 8380357 | Direct |
| 2021-05-17 | Common Stock | P | 5000 | $2.29980 | Acquired | 8385357 | Direct |
| 2021-05-17 | Common Stock | P | 1005 | $2.27 | Acquired | 8386362 | Direct |
| 2021-05-18 | Common Stock | P | 5000 | $2.20 | Acquired | 8391362 | Direct |
| 2021-05-18 | Common Stock | P | 5000 | $2.25 | Acquired | 8396362 | Direct |
| 2021-05-18 | Common Stock | P | 5000 | $2.30 | Acquired | 8401362 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $2.30 to $2.38. The price reported above reflects the average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
More from CLEARONE INC
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 13
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 31
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 17
Regulatory Filings
2026
Mar 13
Major Shareholding Notification
2026
Mar 6